Dupilumab effective in adults with moderate to severe atopic dermatitis: JAMA Jacinthlyn Sylvia19 July 2024 2:30 AM ISTA recent trial by Lisa Beck and team found that continued long-term dupilumab therapy was safe and effective for individuals with moderate to severe...
Managing Atopic Diseases across Age Group Dr. Kamal Kant Kohli27 Feb 2023 11:30 AM ISTAtopy is a genetic tendency to produce high IgE antibodies in response to common allergens, which increases the risk of developing atopic illnesses...
Dupilumab use in Severe Atopic Dermatitis may induce two types of Ocular Surface Diseases Dr. Shravani Dali30 Oct 2021 9:00 AM ISTTwo types of Ocular Surface Diseases were found induced by Dupilumab in Severe Atopic Dermatitis, according to a study published in the Ophthalmology...
Baricitinib- a long term treatment option for moderate to severe atopic dermatitis Dr. Nandita Mohan4 Jun 2021 8:15 AM ISTAccording to recent research, investigators from the Department of Dermatology, George Washington University School of Medicine, Washington, DC have...
Abrocitinib shows promise in managing severe atopic dermatitis;NEJM Dr Satabdi Saha5 April 2021 8:00 PM ISTA recent study has suggested that abrocitinib, at a dose of either 200 mg or 100 mg ,once daily, resulted in significantly greater reductions in signs...
